In conclusion, this study is the first in humans to demonstrate that Lp(a) has a direct, and ApoB-independent, role in dysregulating redox-sensitive inflammatory signaling in the arterial wall, an effect associated with significantly elevated risk for cardiovascular mortality in patients with advanced atherosclerosis. This evidence concerns the gene APOB and atherosclerosis.